Multimedia

Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics?

Author and Disclosure Information

Psoriasis patients are reaching out to their dermatologists with concerns about taking biologics and the risk for coronavirus disease 2019 (COVID-19). Dr. Lawrence Green provides his recommendation, which is for patients to continue their biologics. "If you stop your biologic, and it will take a few months for your psoriasis to come back, but when that happens, if you go back to where you were you're at much more risk for COVID-19 infection than you are right now taking your biologic and controlling your disease," he reports. If patients have had exposure to COVID-19 or develop symptoms, they should stop biologics immediately. Patients taking biologics should exercise extra precautions, as recommended by the Centers for Disease Control and Prevention, to prevent infection.


 

Vidyard Video

Recommended Reading

Disruptions in cancer care in the era of COVID-19
MDedge Hematology and Oncology
Match Day 2020: Online announcements replace celebrations, champagne
MDedge Hematology and Oncology
COVID-19 prompts ‘lifesaving’ policy change for opioid addiction
MDedge Hematology and Oncology
DIY masks: Worth the risk? Researchers are conflicted
MDedge Hematology and Oncology
New ASAM guideline released amid COVID-19 concerns
MDedge Hematology and Oncology
Emergency Rule: Docs can bill for telehealth and COVID-19 tests. Here’s how
MDedge Hematology and Oncology
Preventable diseases could gain a foothold because of COVID-19
MDedge Hematology and Oncology
Should patients with COVID-19 avoid ibuprofen or RAAS antagonists?
MDedge Hematology and Oncology
Webinar confronts unique issues for the bleeding disorders community facing COVID-19
MDedge Hematology and Oncology
Amid hydroxychloroquine hopes, lupus patients face shortages
MDedge Hematology and Oncology